Education
About Us
Working with TipRanks
Follow Us
Abbott Laboratories (DE:ABL)
XETRA:ABL
ABL Analyst Ratings
Strong Buy
18 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ABL Stock 12 Month Forecast
Average Price Target
€127.73
▲(11.61% Upside)
| Highest Price Target€140.64 | Average Price Target€127.73 | Lowest Price Target€112.34 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Argus Research
Reiterated
04/21/25
Raymond James
Reiterated
04/17/25
Piper Sandler
Reiterated
04/17/25
William Blair
Reiterated
04/17/25
Stifel Nicolaus
Reiterated
04/17/25
Morgan Stanley
€102.57→€111.34
Hold
-2.71%
Downside
Reiterated
04/17/25
Abbott price target raised to $127 from $117 at Morgan StanleyAbbott price target raised to $127 from $117 at Morgan Stanley
Barclays
€138.52→€139.4
Buy
21.81%
Upside
Reiterated
04/16/25
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT) and Blueprint Medicines (NASDAQ: BPMC)
Jefferies
€118.36→€120.11
Hold
4.95%
Upside
Reiterated
04/16/25
Abbott price target raised to $137 from $135 at JefferiesAbbott price target raised to $137 from $135 at Jefferies
J.P. Morgan
€118.36
Buy
3.42%
Upside
Reiterated
04/16/25
JPMorgan reiterates Overweight Rating on Abbott Labs (ABT)JPMorgan analyst Robbie Marcus reiterated an Overweight rating and $135.00 price target on Abbott Labs (NYSE: ABT).
Mizuho Securities
€113.97
Hold
-0.41%
Downside
Reiterated
04/16/25
Mizuho reiterates Neutral Rating on Abbott Labs (ABT)Mizuho analyst Anthony Petrone reiterated a Neutral rating and $130.00 price target on Abbott Labs (NYSE: ABT)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Argus Research
Reiterated
04/21/25
Raymond James
Reiterated
04/17/25
Piper Sandler
Reiterated
04/17/25
William Blair
Reiterated
04/17/25
Stifel Nicolaus
Reiterated
04/17/25
Morgan Stanley
€102.57→€111.34
Hold
-2.71%
Downside
Reiterated
04/17/25
Abbott price target raised to $127 from $117 at Morgan StanleyAbbott price target raised to $127 from $117 at Morgan Stanley
Barclays
€138.52→€139.4
Buy
21.81%
Upside
Reiterated
04/16/25
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (NYSE: ABT) and Blueprint Medicines (NASDAQ: BPMC)
Jefferies
€118.36→€120.11
Hold
4.95%
Upside
Reiterated
04/16/25
Abbott price target raised to $137 from $135 at JefferiesAbbott price target raised to $137 from $135 at Jefferies
J.P. Morgan
€118.36
Buy
3.42%
Upside
Reiterated
04/16/25
JPMorgan reiterates Overweight Rating on Abbott Labs (ABT)JPMorgan analyst Robbie Marcus reiterated an Overweight rating and $135.00 price target on Abbott Labs (NYSE: ABT).
Mizuho Securities
€113.97
Hold
-0.41%
Downside
Reiterated
04/16/25
Mizuho reiterates Neutral Rating on Abbott Labs (ABT)Mizuho analyst Anthony Petrone reiterated a Neutral rating and $130.00 price target on Abbott Labs (NYSE: ABT)
Best Analysts Covering Abbott Laboratories
Which Analyst Should I Follow If I Want to Buy DE:ABL and Sell After:
1 Month
xxx
Success Rate
18/26 ratings generated profit
Average Return
+1.10%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +1.10% per trade.
3 Months
xxx
Success Rate
22/26 ratings generated profit
Average Return
+5.52%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 84.62% of your transactions generating a profit, with an average return of +5.52% per trade.
1 Year
2 Years
xxx
Success Rate
19/23 ratings generated profit
Average Return
+15.69%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 82.61% of your transactions generating a profit, with an average return of +15.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ABL Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
0
0
0
0
0
Buy
43
34
27
33
40
Hold
3
2
2
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
36
29
35
43
Each month's total comprises the sum of three months' worth of ratings.
ABL Financial Forecast
ABL Stock Forecast FAQ
What is DE:ABL’s average 12-month price target, according to analysts?
Based on analyst ratings, Abbott Laboratories’s 12-month average price target is 127.73.
What is DE:ABL’s upside potential, based on the analysts’ average price target?
Abbott Laboratories has 11.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Abbott Laboratories a Buy, Sell or Hold?
Abbott Laboratories has a consensus rating of Strong Buy, which is based on 18 buy ratings, 3 hold ratings and 0 sell ratings.
What is Abbott Laboratories’s share price target?
The average share price target for Abbott Laboratories is 127.73. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €140.64 ,and the lowest forecast is €112.34. The average share price target represents 11.61% Increase from the current price of €114.44.
The highest analyst share price target is €140.64 ,and the lowest forecast is €112.34. The average share price target represents 11.61% Increase from the current price of €114.44.
What do analysts say about Abbott Laboratories?
Abbott Laboratories’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.
How can I buy shares of Abbott Laboratories?
To buy shares of DE:ABL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.